Pan Minqiu

[Expert Profile] Pan Minqiu, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in TCM oncology in China, working at the Affiliated Hospital of Hunan Academy of Chinese Medicine. He has long been dedicated to clinical diagnosis, treatment, and scientific research of TCM oncology, liver cancer, lung cancer, and tumor rehabilitation, and is one of the founders and an important leading figure in the TCM oncology discipline in China, enjoying a high reputation in the field of TCM treatment of malignant tumors.

[Education & Career] Professor Pan Minqiu graduated from Hunan College of Traditional Chinese Medicine, and in his early years worked in integrated Chinese and Western medicine clinical practice at a grassroots hospital in Hunan, accumulating rich tumor diagnosis and treatment experience. He has held positions including Vice President of the Affiliated Hospital of Hunan Academy of Chinese Medicine and Chair of the Oncology Branch of the China Association of Chinese Medicine. He has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects. Over decades, he has remained on the front lines of TCM oncology clinical and research work, leading his team to establish a systematic TCM oncology diagnosis and treatment system, transforming the once-questioned proposition of "can traditional Chinese medicine treat tumors" into an evidence-based, nationally influential academic endeavor.

[Areas of Expertise] Professor Pan specializes in TCM syndrome differentiation and treatment of malignant tumors such as liver cancer, lung cancer, gastric cancer, colorectal cancer, and breast cancer, with particular expertise in comprehensive conditioning of middle and late-stage tumors and post-surgical recurrence and metastasis, as well as TCM toxicity reduction and efficacy enhancement for chemoradiotherapy, targeted therapy, and immunotherapy, and tumor rehabilitation management. The "spleen-strengthening and qi-regulating, stasis-resolving and mass-softening, heat-clearing and detoxifying" cancer treatment principles he created emphasize "equal emphasis on supporting healthy qi and eliminating pathogens, simultaneous attack and supplementation." He has profound expertise in oral Chinese herbal compound treatment of middle and late-stage liver cancer and improvement of quality of life. He excels at managing tumor patients with "post-surgical recurrence and metastasis, severe chemoradiotherapy side effects, and weak constitution," helping numerous patients achieve tumor-bearing survival, prolong survival, and put the concept of "human-tumor coexistence, prolonged life with disease" into practice.

[Academic Achievements & Industry Contributions] Professor Pan has led a series of clinical studies on TCM treatment of primary liver cancer and other malignant tumors, systematically verifying the efficacy and safety of TCM cancer treatment formulas, with findings published in authoritative domestic and international journals and receiving the National Science and Technology Progress Award, making him one of the few clinical achievements in the field of TCM oncology to receive a national-level award. He has authored authoritative monographs such as Compendium of Chinese Oncology Treatment, led the development of Chinese TCM oncology diagnosis and treatment standards and expert consensus statements, and actively promoted TCM oncology discipline construction, standardized diagnosis and treatment, and evidence-based development. He has also led the establishment of a national TCM oncology collaboration network, promoting multi-center collaboration in TCM oncology research, and making outstanding contributions to bringing Chinese TCM oncology to the global forefront.

[Clinical Practice & Outstanding Contributions] With decades of medical practice, Professor Pan has treated hundreds of thousands of tumor patients, with significant clinical efficacy, and is praised by countless patients and families as a "master cancer healer." He is serious and responsible with every patient, providing meticulous syndrome differentiation, and always considers patients from financially disadvantaged families, prescribing cost-effective and effective formulas whenever possible. He has received multiple national awards, trained a large number of TCM oncology professionals, and is deeply trusted by patients and respected by peers alike. He is a truly deserving authoritative expert in the field of TCM oncology in China.

[Honors & Reputation] Professor Pan Minqiu holds positions at the Affiliated Hospital of Hunan Academy of Chinese Medicine and serves as Chair of the Oncology Branch of the China Association of Chinese Medicine, among other academic positions. He has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects, and is an authoritative expert in the field of TCM oncology in China. He has led a series of clinical studies on TCM treatment of liver cancer and other tumors, with findings receiving the National Science and Technology Progress Award, authored authoritative monographs such as Compendium of Chinese Oncology Treatment, led the development of Chinese TCM oncology diagnosis and treatment standards, and actively promoted TCM oncology discipline construction and standardized diagnosis and treatment. He has trained a large number of TCM oncology professionals, is known clinically for significant efficacy of the "spleen-strengthening and qi-regulating, stasis-resolving and mass-softening, heat-clearing and detoxifying" cancer treatment method, and is deeply trusted by patients and respected by peers alike.